At Minutia, Katy Digovich is tackling diabetes cell by cell


For Minutia CEO Katy Digovich, diabetes is a personal and professional challenge. Her company is developing potentially game-changing cell therapies.

Previous OHSU's financial picture brightened in Q1 of the fiscal year
Next Denver’s housing market starts to cool, moves closer to balance